Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder

American Psychiatric Association, 1994 Pearlstein, 2000, Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo, J Clin Psychiatry, 61, 101, 10.4088/JCP.v61n0205 Yonkers, 1997, The association between premenstrual dysphoric disorder and other mood disorders, J Clin Psychiatry, 58, 19 Steiner, 2000, Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management, J Psychiatry Neurosci, 25, 459 Angst, 2001, The epidemiology of perimenstrual psychological symptoms, Acta Psychiatr Scand, 104, 110, 10.1034/j.1600-0447.2001.00412.x Wittchen, 2002, Prevalence, incidence and stability of premenstrual dysphoric disorder in the community, Psychol Med, 32, 119, 10.1017/S0033291701004925 Steiner, 2003, The premenstrual symptoms screening tool (PSST) for clinicians, Arch Women Ment Health, 6, 203, 10.1007/s00737-003-0018-4 Dimmock, 2000, Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review, Lancet, 356, 1131, 10.1016/S0140-6736(00)02754-9 Pearlstein, 2002, Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?, Drugs, 62, 1869, 10.2165/00003495-200262130-00004 Macdougall, 2003, Treatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety, Expert Opin Drug Saf, 2, 161, 10.1517/14740338.2.2.161 Cohen, 2002, Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries, Obstet Gynecol, 100, 435, 10.1016/S0029-7844(02)02166-X Freeman, 1999, Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant, J Clin Psychopharmacol, 19, 3, 10.1097/00004714-199902000-00002 Halbreich, 2002, Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder, Obstet Gynecol, 100, 1219, 10.1016/S0029-7844(02)02326-8 Jermain, 1999, Luteal phase sertraline treatment for premenstrual dysphoric disorder, Arch Fam Med, 8, 328, 10.1001/archfami.8.4.328 Steiner, 1997, Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria, Psychopharmacol Bull, 33, 771 Sundblad, 1993, Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial, Neuropsychopharmacology, 9, 133, 10.1038/npp.1993.52 Wikander, 1998, Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?, J Clin Psychopharmacol, 18, 390, 10.1097/00004714-199810000-00007 Young, 1998, Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomised, double-blind, placebo-controlled crossover trial, J Clin Psychiatry, 59, 76, 10.4088/JCP.v59n0206 Cohen, 2004, Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial, Psychosom Med, 66, 707, 10.1097/01.psy.0000140005.94790.9c Yonkers, 2003, Paroxetine controlled release is effective in treating premenstrual dysphoric disorder: a pooled analysis of three trials, Obstet Gynecol, 101, 110S Guy, 1976 Montgomery, 1979, A new depression scale designed to be sensitive to change, Br J Psychiatry, 134, 382, 10.1192/bjp.134.4.382 Steiner, 1980, Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales, Acta Psychiatr Scand, 62, 177, 10.1111/j.1600-0447.1980.tb00605.x Sheehan, 1996, The measurement of disability, Int Clin Psychopharmacol, 89, 10.1097/00004850-199606003-00015 Steiner, 1999, The measurement of premenstrual mood symptoms, J Affect Disord, 53, 269, 10.1016/S0165-0327(98)00121-9 Judge, 2002, Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment, Int Clin Psychopharmacol, 17, 217, 10.1097/00004850-200209000-00002 Michelson, 2000, Interruption of selective serotonin reuptake inhibitor treatment, Br J Psychiatry, 176, 363, 10.1192/bjp.176.4.363 Rosenbaum, 1998, Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial, Biol Psychiatry, 44, 77, 10.1016/S0006-3223(98)00126-7